title: Prostate cancer risk calculators using ERSPC-derived data underestimate the risk if the WHO IRP 96/670 standard is used in prostate-specific antigen analysis.
authors.affiliation: Department of Chemical Pathology, Beaumont Hospital, Dublin, Ireland; Biomedical Sciences, Ulster University, Coleraine, Northern Ireland, UK. Electronic address: billtormey@gmail.com.
authors.forename: William Patrick
authors.initials: WP
authors.lastname: Tormey
mesh_terms: D000465:Algorithms; D055088:Early Detection of Cancer / Q000592:standards*; D006801:Humans; D007118:Immunoassay / Q000592:standards*; D007610:Kallikreins / Q000097:blood*; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000175:diagnosis; D018570:Risk Assessment; D014944:World Health Organization
chemical_list: C549870:KLK3 protein, human; D007610:Kallikreins; D017430:Prostate-Specific Antigen